FDA Status Updates On Citizen Petitions Would Not Signal Decision Pending
This article was originally published in The Rose Sheet
Executive Summary
FDA dockets-management staffers are preparing to add live status updates and a listing of all pending citizen petitions to the agency's website. The move potentially could provide some reassurance to sponsors.
You may also be interested in...
FDA Balks At CIR Public-Private Partnership In FY 2017 Budget Request
Based on its fiscal 2017 budget justification, FDA does not support a congressional proposal to formalize Cosmetic Ingredient Review safety assessments through a public-private partnership. The agency still intends to prepare a report on the subject, as directed by Senate and House appropriations committees, but characterizes the proposed framework as "inappropriate."
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
US FDA Hopes Food, Inspection Office Reorg Bolsters Innovative Clinical Trial Adoption
Ensuring inspectors understand the innovative trial designs in use before an inspection will be important to increasing industry confidence in their use, CDER Director Patrizia Cavazzoni said.